SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual ...

Dax Zey was born on January 1, 2026. It was Herasight’s 11th baby, and Chase and Arthur’s first. He was as healthy as his ...

Science has long taken inspiration from the natural world, and few natural designs are as iconic as the helical shape that ...

Language may feel like one of the most distinctly human things about you, but the genetic groundwork for it appears to be ...

Humans wiped out the bluebuck in Africa around 200 years ago. Bringing it back is both ethically and technologically ...

For one 15-year-old in Nepal, the misery continued long after the blisters burst. After some of her crusty scabs began to ...

Screening guidelines often fail to pinpoint who’s at risk, and few people who are eligible for screening actually get checked ...

A deep dive into synaesthesia reveals the neurological theories behind why some people "see" music and "taste" words.

Rejuvenation is one of the newest and most promising developments in longevity research, a field that began in earnest in ...

Agreement includes up to $155 million in non-dilutive funding with an upfront payment of $35 million and a $5 million equity investment - - Strategic financing to accelerate development of ...

Women of colour face an 11-year wait for an endometriosis diagnosis in the UK, leaving many in pain without a pathway to ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American ...